27/05/2024  17:14:23 Diferencia - Volumen Bid9:00:07 Ask9:00:07 Capitalización de mecado Dividendo A. P/E Ratio
94.88EUR - 175
Volumen de negocios: 16,600.18
-Volumen de oferta: - -Tamaño/ Volumen/ Formato de Ask: - 11.1 mil millonesEUR 0.91% 30.94

Descripción de negocio

bioMérieux S.A. is one of the world leaders in the field of in vitro diagnostics for over 50 years. bioMérieux is present in more than 160 countries through 42 subsidiaries and a large network of distributors. bioMérieux provides diagnostic solutions (reagents, instruments, software and services) which determine the source of disease and contamination to improve patient health and ensure product safety. In clinical applications, the Company offers a wide range of solutions for managing infectious diseases, cardiovascular diseases and targeted cancers. For the agri-food, cosmetics and pharmaceutical industries, bioMérieux provides solutions for the enumeration of microbial flora, detection of specific pathogenic bacteria, monitoring of air and surface quality and sterility testing.
 

Consejo de gestión & Consejo de supervisión

CEO
Pierre Boulud
Consejo de gestión
Guillaume Bouhours, Pierre Charbonnier, Audrey Dauvet, François Lacoste, Valérie Leyldé, Mark Miller, Yasha Mitrotti, Jennifer Zinn
Consejo de supervisión
Alexandre Mérieux, Alain Mérieux, Jean-Luc Bélingard, Marie-Hélène Habert-Dassault, Philippe Archinard, Harold Boël, Fanny Letier, Marie-Paule Kieny, Sylvain Orenga
 

Datos de la empresa

Nombre: bioMerieux S.A.
Dirección: Chemin de l'Orme,F-69280 Marcy l'Etoile
Teléfono: +33-4-7887-2000
Fax: +33-4-7887-2090
E-mail: -
Internet: www.biomerieux.com
Industria: Healthcare
Sector: Medical Products
Subsector: Advanced Medical Devices
Fin del año financiero: 31/12
Acciones de libre circulación: 33.97%
Fecha de OPI: -

Relación con inversores

Nombre: Sylvain Morgeau
IR teléfono: +33-4-7887-2237
IR-fax: -
IR e-mail: investor.relations@b...eux.com investor.relations@biomerieux.com

Accionistas mayoritarios

Institut Mérieux
 
58.90%
Otros
 
34.77%
SITAM Belgique
 
4.60%
Sofina SA
 
1.73%